Molecular imaging of the pulmonary circulation in health and disease.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 25360422)

Published in Clin Transl Imaging on September 09, 2014

Authors

Jocelyn Dupuis1, François Harel2, Quang T Nguyen3

Author Affiliations

1: Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, QC H1T 1C8 Canada ; Department of Medicine, Université de Montréal, Montreal, QC Canada.
2: Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, QC H1T 1C8 Canada ; Department of Radiology, Radio-Oncology and Nuclear Medicine Université de Montréal, Montreal, QC Canada.
3: Research Center, Montreal Heart Institute, 5000 Belanger Street, Montreal, QC H1T 1C8 Canada.

Associated clinical trials:

Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation | NCT01539889

Articles cited by this

(truncated to the top 100)

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J (2009) 14.06

Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05

Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2013) 8.29

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol (2009) 7.94

The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev (1951) 7.32

Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med (2006) 6.06

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation (2010) 5.87

Point: Gravity is the major factor determining the distribution of blood flow in the human lung. J Appl Physiol (1985) (2007) 5.38

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

DISTRIBUTION OF BLOOD FLOW IN ISOLATED LUNG; RELATION TO VASCULAR AND ALVEOLAR PRESSURES. J Appl Physiol (1964) 2.89

Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med (2013) 2.36

Regional cerebral blood flow in man determined by the initial slope of the clearance of intra-arterially injected 133Xe. Stroke (1974) 2.26

Counterpoint: Gravity is not the major factor determining the distribution of blood flow in the healthy human lung. J Appl Physiol (1985) (2008) 2.18

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. J Nucl Med (2006) 2.15

Vertical gradients in regional lung density and perfusion in the supine human lung: the Slinky effect. J Appl Physiol (1985) (2007) 1.92

Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J Appl Physiol (1985) (2002) 1.83

Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J (2008) 1.77

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med (2010) 1.67

SUSPENSIONS OF RADIOALBUMIN AGGREGATES FOR PHOTOSCANNING THE LIVER, SPLEEN, LUNG AND OTHER ORGANS. J Nucl Med (1964) 1.59

Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun (1993) 1.51

Effects of hemodynamics on global and regional lung perfusion: a quantitative lung perfusion study by magnetic resonance imaging. Circ Cardiovasc Imaging (2012) 1.48

Studies of the circulation with radioactive microspheres. Invest Radiol (1970) 1.43

The use of radioactive carbon dioxide to measure regional blood flow in the lungs of patients with pulmonary disease. J Clin Invest (1961) 1.43

Effect of lung volume on the distribution of pulmonary blood flow in man. Respir Physiol (1968) 1.43

Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.42

Quantification of regional ventilation-perfusion ratios with PET. J Nucl Med (2003) 1.42

Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J (2012) 1.39

Fractal modeling of pulmonary blood flow heterogeneity. J Appl Physiol (1985) (1991) 1.25

Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation (1996) 1.22

Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors. J Appl Physiol (1985) (1996) 1.21

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest (2003) 1.21

Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT. J Nucl Med (2009) 1.18

Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med (1994) 1.15

Gravity is an important but secondary determinant of regional pulmonary blood flow in upright primates. J Appl Physiol (1985) (1999) 1.14

An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology (1995) 1.08

Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. Circ Heart Fail (2013) 1.05

Imaging lung perfusion. J Appl Physiol (1985) (2012) 1.02

Challenges in the diagnosis and treatment of pulmonary arterial hypertension. Eur Respir Rev (2012) 1.02

Pathology of pulmonary hypertension. Clin Chest Med (2013) 1.01

Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J (2011) 1.00

Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues. Cell Tissue Res (2002) 1.00

Metabolic functions of the pulmonary circulation. Circ Res (1982) 0.99

Physiological imaging of the lung: single-photon-emission computed tomography (SPECT). J Appl Physiol (1985) (2006) 0.97

Lung function studies using short-lived 81mKr and the scintillation camera. J Nucl Med (1970) 0.96

Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V. Proc Am Thorac Soc (2009) 0.96

Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br J Pharmacol (2005) 0.96

Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation (2013) 0.95

Physiological evaluation of a new quantitative SPECT method measuring regional ventilation and perfusion. J Appl Physiol (1985) (2003) 0.95

Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis. J Nucl Med (2007) 0.95

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation (2000) 0.94

Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide. Anticancer Res (2005) 0.94

Point:Counterpoint: Gravity is/is not the major factor determining the distribution of blood flow in the human lung. J Appl Physiol (1985) (2008) 0.94

(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study. Pulm Circ (2012) 0.93

Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med (1998) 0.92

Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent. J Nucl Med (2004) 0.92

Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. Arthritis Rheum (2008) 0.91

Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. J Nucl Med (2007) 0.91

Endothelin-receptor antagonists in pulmonary hypertension. Lancet (2001) 0.90

Chronically elevated endothelin levels reduce pulmonary vascular reactivity to nitric oxide. Am J Respir Crit Care Med (2004) 0.89

Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET. J Nucl Med (2004) 0.88

Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension. Chest (2006) 0.88

Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J (1998) 0.88

Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin. Biochem Soc Trans (2004) 0.87

Hypoxia has a greater effect than exercise on the redistribution of pulmonary blood flow in swine. J Appl Physiol (1985) (2007) 0.87

Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis. J Vasc Res (2010) 0.87

Effect of extra-alveolar vessels on distribution of blood flow in the dog lung. J Appl Physiol (1968) 0.87

EARLY CLINICAL APPLICATIONS OF LUNG SCINTISCANNING. Radiology (1964) 0.87

Pulmonary studies using positron emission tomography. Eur Respir J (1995) 0.86

Positron emission tomography imaging of regional pulmonary perfusion and ventilation. Proc Am Thorac Soc (2005) 0.86

Novel distribution of adrenomedullin-immunoreactive cells in human tissues. Histochem Cell Biol (1999) 0.86

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans. Circulation (1999) 0.85

Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin. Clin Sci (Lond) (2005) 0.85

Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. J Nucl Med (2006) 0.85

Inhomogeneity of pulmonary perfusion during sustained microgravity on SLS-1. J Appl Physiol (1985) (1994) 0.84

Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension. PLoS One (2012) 0.84

The acute effects of pneumonectomy on pulmonary vascular impedance in the dog. Ann Thorac Surg (1987) 0.83

In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med (2003) 0.83

Visualization of pulmonary artery occlusion by photoscanning. JAMA (1963) 0.83

[11C]-MeJDTic: a novel radioligand for kappa-opioid receptor positron emission tomography imaging. Nucl Med Biol (2008) 0.82

PulmoBind, an adrenomedullin-based molecular lung imaging tool. J Nucl Med (2013) 0.82

Lung serotonin metabolism. Clin Chest Med (1989) 0.82

Peripheral distribution and gene expression of adrenomedullin in the rat: possible source of blood adrenomedullin. Neuropeptides (2000) 0.82

Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin. J Nucl Med (2009) 0.82

Distribution of extravascular fluid volumes in isolated perfused lungs measured with H215O. J Clin Invest (1976) 0.81

Immunohistochemical detection of the calcitonin receptor-like receptor protein in the microvasculature of rat endothelium. Eur J Pharmacol (2003) 0.81

Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects. Nucl Med Biol (2006) 0.81

Last word on Point:Counterpoint: Gravity is/is not the major factor determining the distribution of blood flow in the human lung. J Appl Physiol (1985) (2008) 0.81

Radionuclide imaging of acute lung transplant rejection with annexin V. Chest (2000) 0.81

Use of adrenomedullin derivatives for molecular imaging of pulmonary circulation. J Nucl Med (2008) 0.80

Uptake of fentanyl in pulmonary endothelium. J Pharmacol Exp Ther (1999) 0.80

Pulmonary involvement in Behçet's disease: evaluation of 123 I-MIBG retention. Nucl Med Commun (2001) 0.80

Effect of body posture on spatial distribution of pulmonary blood flow. J Appl Physiol (1985) (1988) 0.79

Imaging endothelin ET(B) receptors using [18F]-BQ3020: in vitro characterization and positron emission tomography (microPET). Exp Biol Med (Maywood) (2006) 0.79

Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension. J Card Fail (2004) 0.79

First pass uptake of 14C-propranolol by the lung. Thorax (1979) 0.79

Impaired lung uptake of propranolol in human pulmonary emphysema. Am Rev Respir Dis (1982) 0.79

Demonstration of pulmonary perfusion heterogeneity induced by gravity and lung inflation using arterial spin labeling. Eur J Radiol (2009) 0.79

Regional pulmonary blood flow during rest, tilt, and exercise in unanesthetized dogs. J Appl Physiol (1985) (1995) 0.79

Pulmonary extraction of serotonin and propranolol in patients with adult respiratory distress syndrome. Am Rev Respir Dis (1985) 0.79

Synthesis and evaluation of a series of 99mTc(CO)3+ lisinopril complexes for in vivo imaging of angiotensin-converting enzyme expression. J Nucl Med (2008) 0.78